CoChat
Sign Up
Cited by 39

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Low- and high-risk human papillomavirus E7 proteins regulate p130 differently

Barrow-Laing, Lisa, Chen, Wei, Roman, Ann·2010·Virology
DOI 10.1016/j.virol.2010.01.034PMC PMC2861914
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.virol.2010.01.034

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 50

  1. Armstrong, 1992, Mutagenesis of human papillomavirus types 6 and 16 E7 open reading frames alters the electrophoretic mobility of the expressed proteins, J. Gen. Virol., 73, 1275, 10.1099/0022-1317-73-5-1275 · DOI
  2. Baldwin, 2006, Human papillomavirus E7 oncoprotein dysregulates steroid receptor coactivator 1 localization and function, J. Virol., 80, 6669, 10.1128/JVI.02497-05 · DOI
  3. Banerjee, 2006, Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes, J. Virol., 80, 6517, 10.1128/JVI.02499-05 · DOI
  4. Cam, 2003, Emerging roles for E2F: beyond the G1/S transition and DNA replication, Cancer Cell, 3, 311, 10.1016/S1535-6108(03)00080-1 · DOI
  5. Chestukhin, 2002, Nucleocytoplasmic shuttling of p130/RBL2: novel regulatory mechanism, Mol. Cell. Biol., 22, 453, 10.1128/MCB.22.2.453-468.2002 · DOI
  6. Ciccolini, 1994, Functional studies of E7 proteins from different HPV types, Oncogene, 9, 2633
  7. Classon, 2001, p107 and p130: versatile proteins with interesting pockets, Exp. Cell Res., 264, 135, 10.1006/excr.2000.5135 · DOI
  8. Claudio, 2002, The retinoblastoma family: twins or distant cousins?, Genome Biol., 3, 10.1186/gb-2002-3-9-reviews3012 · DOI
  9. Collins, 2005, Interactions with pocket proteins contribute to the role of human papillomavirus type 16 E7 in the papillomavirus life cycle, J. Virol., 79, 14769, 10.1128/JVI.79.23.14769-14780.2005 · DOI
  10. DeCaprio, 1992, The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression, Proc. Natl. Acad. Sci. U. S. A., 89, 1795, 10.1073/pnas.89.5.1795 · DOI
  11. Demers, 1994, Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7, Proc. Natl. Acad. Sci. U. S. A., 91, 4382, 10.1073/pnas.91.10.4382 · DOI · Paper page
  12. Deshaies, 1999, SCF and Cullin/Ring H2-based ubiquitin ligases, Annu. Rev. Cell Dev. Biol., 15, 435, 10.1146/annurev.cellbio.15.1.435 · DOI
  13. Drain, 2002, Determinants of cervical cancer rates in developing countries, Intl. J. of Cancer, 100, 199, 10.1002/ijc.10453 · DOI
  14. Dyson, 1989, The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product, Science, 243, 934, 10.1126/science.2537532 · DOI · Paper page
  15. Flores, 2000, The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle, J. Virol., 74, 6622, 10.1128/JVI.74.14.6622-6631.2000 · DOI
  16. Gage, 1990, The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties, J. Virol., 64, 723, 10.1128/jvi.64.2.723-730.1990 · DOI · Paper page
  17. Genovese, 2008, Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes, J. Virol., 82, 4862, 10.1128/JVI.01202-07 · DOI
  18. Gonzalez, 2001, Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7, J. Virol., 75, 7583, 10.1128/JVI.75.16.7583-7591.2001 · DOI · Paper page
  19. Guccione, 2002, Comparative analysis of the intracellular location of the high- and low-risk human papillomavirus oncoproteins, Virology, 293, 20, 10.1006/viro.2001.1290 · DOI · Paper page
  20. Hebner, 2006, Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity, Rev. Med. Virol., 16, 83, 10.1002/rmv.488 · DOI
  21. Helin, 1993, Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation, Genes Dev., 7, 1850, 10.1101/gad.7.10.1850 · DOI
  22. Huh, 2005, Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600, Proc. Natl. Acad. Sci. U. S. A., 102, 11492, 10.1073/pnas.0505337102 · DOI · Paper page
  23. Huh, 2007, Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor, J. Virol., 81, 9737, 10.1128/JVI.00881-07 · DOI · Paper page
  24. Jewers, 1992, Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes, J. Virol., 66, 1329, 10.1128/jvi.66.3.1329-1335.1992 · DOI
  25. Kehn, 2005, The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation, Oncogene, 24, 525, 10.1038/sj.onc.1208105 · DOI
  26. Knapp, 2009, Identification of the nuclear localization and export signals of high risk HPV16 E7 oncoprotein, Virology, 383, 60, 10.1016/j.virol.2008.09.037 · DOI
  27. Kubo, 1999, The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4, Clin. Cancer Res., 5, 4279
  28. Litovchick, 2004, Glycogen synthase kinase 3 phosphorylates RBL2/p130 during quiescence, Mol. Cell. Biol., 24, 8970, 10.1128/MCB.24.20.8970-8980.2004 · DOI
  29. Longworth, 2004, Pathogenesis of human papillomaviruses in differentiating epithelia, Microbiol. Mol. Biol. Rev., 68, 362, 10.1128/MMBR.68.2.362-372.2004 · DOI
  30. Ludwig, 1999, Diminished rev-mediated stimulation of human immunodeficiency virus type 1 protein synthesis is a hallmark of human astrocytes, J. Virol., 73, 8279, 10.1128/JVI.73.10.8279-8289.1999 · DOI
  31. McLaughlin-Drubin, 2005, The role of the human papillomavirus type 18 E7 oncoprotein during the complete viral life cycle, Virology, 338, 61, 10.1016/j.virol.2005.04.036 · DOI
  32. Meijer, 1997, Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5, Eur. J. Biochem., 243, 527, 10.1111/j.1432-1033.1997.t01-2-00527.x · DOI · Paper page
  33. Munger, 2001, Biological activities and molecular targets of the human papillomavirus E7 oncoprotein, Oncogene, 20, 7888, 10.1038/sj.onc.1204860 · DOI
  34. Nguyen, 2007, Human papillomavirus type 16 E7 oncoprotein associates with the centrosomal component gamma-tubulin, J. Virol., 81, 13533, 10.1128/JVI.01669-07 · DOI · Paper page
  35. Oh, 2004, Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11, J. Virol., 78, 2620, 10.1128/JVI.78.5.2620-2626.2004 · DOI
  36. Sedlacek, 2001, Mechanisms of action of flavopiridol, Crit. Rev. Oncol. Hematol., 38, 139, 10.1016/S1040-8428(00)00124-4 · DOI
  37. Shirodkar, 1992, The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner, Cell, 68, 157, 10.1016/0092-8674(92)90214-W · DOI
  38. Smith-McCune, 1999, Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130, Proc. Natl. Acad. Sci. U. S. A., 96, 6999, 10.1073/pnas.96.12.6999 · DOI · Paper page
  39. Smotkin, 1987, The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein, J. Virol., 61, 1686, 10.1128/jvi.61.5.1686-1689.1987 · DOI · Paper page
  40. Snijders, 2006, HPV-mediated cervical carcinogenesis: concepts and clinical implications, J. Pathol., 208, 152, 10.1002/path.1866 · DOI
  41. Srinivasan, 1997, The amino-terminal transforming region of simian virus 40 large T and small t antigens functions as a J domain, Mol. Cell. Biol., 17, 4761, 10.1128/MCB.17.8.4761 · DOI · Paper page
  42. Stubdal, 1997, Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen, Mol. Cell. Biol., 17, 4979, 10.1128/MCB.17.9.4979 · DOI
  43. Tedesco, 2002, The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSkp2, Genes Dev., 16, 2946, 10.1101/gad.1011202 · DOI
  44. von Mikecz, 2006, The nuclear ubiquitin–proteasome system, J. Cell Sci., 119, 1977, 10.1242/jcs.03008 · DOI
  45. Wang, 2009, Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes, Genes Dev., 23, 181, 10.1101/gad.1735109 · DOI
  46. Westbrook, 2002, E7 abolishes raf-induced arrest via mislocalization of p21(Cip1), Mol. Cell. Biol., 22, 7041, 10.1128/MCB.22.20.7041-7052.2002 · DOI
  47. Wolff, 1997, Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA, Chem. Biol., 4, 139, 10.1016/S1074-5521(97)90257-X · DOI
  48. Zhang, 2006, The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation, Proc. Natl. Acad. Sci. U. S. A., 103, 437, 10.1073/pnas.0510012103 · DOI · Paper page
  49. zur Hausen, 2000, Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis, J. Natl. Cancer Inst., 92, 690, 10.1093/jnci/92.9.690 · DOI
  50. zur Hausen, 2002, Papillomaviruses and cancer: from basic studies to clinical application, Nat. Rev. Cancer, 2, 342, 10.1038/nrc798 · DOI

Cited by

See all 39

Metadata

Authors
Barrow-Laing, L., Chen, W., & Roman, A.
Venue
Virology
Publisher
Elsevier BV
Published
2010-05
Volume
400
Issue
2
Pages
233-239
ISSN
0042-6822
DOI
10.1016/j.virol.2010.01.034
PMC
PMC2861914
Cited by
39
References
2
Language
en
Licence
Funders
  • National Institutes of Health (R01 AI49294)
  • Indiana University School of Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review